GI bleeding treatment devices market seen reaching $1.39B by 2030

The gastrointestinal bleeding treatment devices market is projected to grow from $0.92 billion in 2025 to $1 billion in 2026, then reach $1.39 billion by 2030. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth as hospitals and outpatient centers expand GI care.

Why it matters: - Gastrointestinal bleeding treatment devices are tied to urgent care for bleeding anywhere in the digestive tract, including the stomach, esophagus, small intestine, rectum, anus and large intestine. - Rising demand for GI intervention tools reflects more diagnosed gastrointestinal disease and more use of endoscopic treatment. - The market outlook points to continued spending on minimally invasive bleeding control methods and advanced endoscopy platforms.

What happened: - The gastrointestinal bleeding treatment devices market is projected to grow from $0.92 billion in 2025 to $1 billion in 2026. - The report forecasts the market will reach $1.39 billion by 2030. - That implies an 8.7% CAGR from 2025 to 2026 and an 8.6% CAGR from 2026 to 2030. - The Business Research Company released the market report in London on Aug. 7, 2026. - The report covers market dynamics from 2025 to 2035. - A free sample of the report is available. - The full market report is also available online.

The details: - Market growth has been driven by more gastrointestinal disorders, higher peptic ulcer disease prevalence, wider use of endoscopic diagnostic techniques, expansion of hospital-based GI interventions and more advanced endoscopy equipment. - The report says future growth will be supported by next-generation endoscopic devices, more outpatient GI procedures, earlier bleeding detection, more ambulatory surgical centers and higher investment in GI care technologies. - The report highlights several trend areas, including advanced endoscopic hemostasis tools, minimally invasive GI bleeding treatments, thermal ablation technologies, mechanical hemostatic solutions and rapid bleeding control methods. - GI bleeding often requires specialized treatment devices because the condition signals underlying health issues that need timely medical intervention. - The report identifies North America as the largest regional market in 2025. - The Asia-Pacific region is expected to post the fastest growth during the forecast period. - Other regions covered include South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market is shifting toward faster, less invasive procedures that can be deployed in hospitals and outpatient settings. - Growth in ambulatory surgical centers suggests more GI bleeding care may move outside traditional hospital settings. - The rising prevalence of inflammatory bowel disease in Canada underscores the broader disease burden feeding demand for treatment devices. - In October 2024, the National Library of Medicine reported 825 cases per 100,000 people in Canada, affecting more than 320,000 individuals. - The same source projected the figure could rise to 1.1% of the population, or about 470,000 Canadians, by 2035.

What's next: - Device makers are likely to focus on hemostasis tools that offer quicker bleeding control and more precise thermal treatment. - Growth opportunities are expected to be strongest in Asia-Pacific as GI procedure volumes and care capacity expand. - The report says updated graphics, TAM analysis, company scoring matrices and forecasting dashboards are included in its 2026 edition.

The bottom line: - GI bleeding treatment devices are moving into a steady-growth phase, with demand shaped by more GI disease, more outpatient care and broader adoption of advanced endoscopic treatment.